[FORM 10-K (Mark One) December 31, 2012 For the fiscal year ended: For the transition period from ____________to _____________ Commission File No. 001-34566 CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building, 19 Chaoyang Park Road (+86) 10-6598-3111 Title of each class Name of each exchange] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in registration statements (No. 333-171069 and 333-182624) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 13, 2013, with respect to the consolidated balance sheets of China Biologic Products,] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer)]

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): December 24, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) People’s Republic of China 18th Floor, Jialong International Building 86-10-6598-3166 (Former name or former address, if changed since last report) _______________________________________________ see ITEM]

[CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES ____________________________________________________________ 1. He is the duly elected and acting Chief Executive Officer of China Biologic Products, Inc., a Delaware corporation (the “ Corporation ”). Board Preferred Stock ”), of the Corporation designated as Series A Participating Preferred Stock: RESOLVED Charter ”), the Board does hereby provide for the issuance of a series] [PREFERRED SHARES RIGHTS AGREEMENT Dated as of November 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION as Rights Agent TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 11 12 Section 6. Transfer, Split Up, Combination and Exchange] [CHINA BIOLOGIC PRODUCTS, INC. ADOPTS STOCKHOLDER RIGHTS PLAN The stockholder rights plan, which has a term of two years, is designed to guard against partial tender offers and other coercive tactics to gain control or undue influence of China Biologic without offering a fair and adequate price and terms to China Biologic’s stockholders. The plan does not prevent China Biologic’s] [FORM 8-K Current Report Date of Report (Date of earliest event reported): CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building 19 Chaoyang Park Road 86-10-6698-3166 (Former name or address, if changed since last report) Item 1.01. Entry into a Material Definitive Agreement. On November 19, 2012, the Board]